Science and culture at the heart of Italy’s relaunch
07 April 2021
Science and culture at the heart of Italy’s relaunch
On 13 April at 10.00 Human Technopole Foundation and Associazione Civita organise a debate among representatives of the cultural, research, political and industrial world to discuss the potential role of science and culture in relaunching the Italian economy on the eve of the presentation of the National Recovery and Resilience Plan.
This event is the first in a series of joint initiatives between Human Technopole and Associazione Civita following a memorandum of understanding jointly signed at the end of 2020 for the implementation of activities to promote scientific culture and dissemination of knowledge.
The COVID-19 pandemic crisis has had a dramatic impact on the Italian economy, which today looks with great expectations to the Next Generation EU Programme. What role can culture and scientific research play in promoting the relaunch of the Italian economy? Could the National Plan for Recovery and Resilience be an opportunity to start investing in these sectors again, placing them at the heart of the country’s rebirth?
The event will feature Simonetta Giordani President of Associazione Civita, Anna Ascani Undersecretary of the Ministry for Economic Development, Marco Simoni President of the Human Technopole Foundation, Innocenzo Cipolletta President Confindustria Cultura Italia, Federica Zalabra Director Palazzo Altieri – Oriolo Romano e Villa Giustiniani – Bassano Romano and Pasquale Frega Country President and CEO of Novartis and will be moderated by Paolo Conti, journalist and columnist for Corriere della Sera.
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.
Manage Cookie Consent
This website uses technical cookies to provide you with a better browsing experience and, subject to your consent, profiling cookies to offer you information and advertising in line with your preferences. For more details, you can consult our cookie policy by clicking on the link below, or set your preferences by clicking "set preferences". By selecting "accept cookies" you consent to the use of all types of cookies while you can revoke your consent by clicking on "refuse". By deciding to refuse or closing the banner, only the technical cookies necessary for the correct functioning of the site will be activated.
Technical cookies (required)
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Third party cookies for statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Third party cookies for profiling
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.